Tennessee Multistate Pharmacy Jurisprudence Examination (MPJE) Practice Exam 2026 - Free MPJE Practice Questions and Study Guide

The correct answer highlights that when submitting information to the Controlled Substance Monitoring Database (CSMD), it is essential to include the drug, its strength, and the quantity. This data is crucial for monitoring prescriptions and ensuring compliance with regulations regarding controlled substances.

Including the drug allows the monitoring system to track specific substances that are classified as controlled, while the strength provides details on the potency of the medication. The quantity recorded is vital for understanding usage patterns and identifying potential abuse or diversion of controlled substances. By requiring this specific information, the CSMD can effectively analyze and monitor prescription data to help safeguard public health and support efforts to combat the opioid crisis and other substance misuse issues.

In this context, while brand name may provide some identification, it is insufficient alone for effective monitoring, and patient allergy history, along with dosage form, while important in patient care, does not contribute directly to the monitoring of controlled substances in the database. Thus, they do not fulfill the specific requirements related to CSMD reporting.